Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q2 2026 Earnings

11MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.68

-0.63

-0.59

-0.54

Details

Expected EPS

-0.553408

Actual EPS

-0.61

Surprise EPS

-0.06

Surprise Percent

+10.23%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.61 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.